Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)

Abroad (travel likely)Recruiting

Conditions

Small Bowel Cancer · Colorectal Cancer · Appendiceal Cancer · Biliary Cancer · Gall Bladder Cancer · Intrahepatic Cholangiocarcinoma · Extrahepatic Cholangiocarcinoma · Oligoprogressive

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of California, Davis Comprehensive Cancer Center, Sacramento, California, United States
Contact: Study coordinator (Office of Clinical Research) · OCRReferral@health.ucdavis.edu · 916-382-6970
Contact: Principal Investigator (Edward Kim, MD, PhD)

Study leads

Edward Kim, MD, PhD
Principal Investigator
University of California, Davis

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Phase 1 Study of IM-1617 in Participants With Advanced Cancer

Colorectal Cancer · Non-Small Cell Lung Cancer · Breast Cancer

Abroad (travel likely)RecruitingPHASE1

Sarasota, United States · Irving, United States

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

Cancer · PDAC - Pancreatic Ductal Adenocarcinoma · NSCLC (Non-small Cell Lung Cancer)

Abroad (travel likely)RecruitingPHASE1

Orlando, United States · Boston, United States

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

End of Life · Cancer

Abroad (travel likely)Recruiting

Birmingham, United States · Mobile, United States

18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors

Clear Cell Renal Cell Cancer (ccRCC) · Urothelial Carcinoma (UC) · Colorectal Cancer

Abroad (travel likely)Recruiting

Beijing, China